The major finding in this work is the discovery of TRIM11-mediated drug resistance of NPC, which targeted Daple for its degradation via p62-selective autophagy to activate β-catenin/ABCC9 signals (Fig. 7j). The gene discussed is TRIM11; the disease is nasopharyngeal carcinoma.